OpenPhenom is a non-commercial, publicly available foundation model built on microscopy data that has set the new "gold ...

Multiple clinical trial milestones were achieved, including encouraging topline data for a Phase 2 trial in CCM, the first ...

Google DeepMind proposes a technique called Layer Tying. Instead of processing the input through a large number of layers, it ...

and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis. According to Benzinga Pro, Recursion Pharmaceuticals's ...

If AI systems can do their own AI research, they can come up with superior AI architectures and methods. Via a simple ...

The Indonesian artist’s latest videos combine quantum physics and mysticism, opening new portals through which to explore ...

“Given the ownership structure, which is basically three quarters for Recursion shareholders, one quarter Exscientia shareholders, it's hard for me to imagine that they would have done the deal ...

Recursion Pharmaceuticals ... a tech-driven platform that will enable patient-centric target discovery, and structure-based drug design and will implement 2D and 3D AI tools to innovate drug ...